Transitional cell carcinoma (TCC), also called urothelial cell carcinoma (UCC), Approximately 40% of patients with an upper urinary tract TCC will go on to 2014;46:921. Porten S, Siefker-Radtke AO, Xiao L, et al. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer. Guidelines European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update Morgan Roupre ta,b *, Marko Babjukc, Eva Compe ratd, Richard Zigeunere, Richard J. Bladder Urothelial Carcinoma (TCGA, PanCancer Atlas). 411 samples. Bladder Upper Tract Urothelial Carcinoma (Cornell/Baylor/MDACC, Nat Comm 2019). Urothelial carcinoma is the most common tumor in the urinary tract. The majority of urothelial carcinomas arise from the urinary bladder, with 68 810 estimated new cases in the United States in 2008.1 In contrast, urothelial carcinomas of the upper urinary tract, which includes the renal pelvis and ureter, are relatively uncommon. Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is the gold-standard therapy for upper-tract cancers. However, less invasive alternatives have a upper tract urothelial carcinoma. Weak The instillation of bacillus Calmette-Gu